A continuous service
Described in our first routine GCP inspection by the MHRA in 2007, as a “centre of excellence” and providing “a superior service”.
We have worked tirelessly to establish a mechanism that is continuously available and works to exceed regulatory requirements thus keeping the patient’s safety a priority.
Calls answered within 20 seconds
Preventing unnecessary unblindings in last 3 years
SAE reported to Pharmacovigilance within 24 hours
Emergency ‘out of hours’ answered within 4 minutes
Recent News and Events
Read about our latest events, news and announcements…
Have you ever tried to enrol on to one of your own trials as a ‘Mystery Shopper’?
Have you ever tried to enrol on to one of your own trials as a ‘Mystery Shopper’? At ESMS we have been mystery shopping for enrolment on trials sponsored by a variety of Pharma companies and the experience [...]
Outsourcing in Clinical Trials | Nordics 2022
Outsourcing in Clinical Trials Nordics | Copenhagen 2022 ESMS Global will be sponsoring and attending the 2022 OCT & CTS Nordics event October 25th - 26th. Vester Søgade 6, 1601 København, Denmark With all the latest content, [...]
DIA European Medical Information and Communications Conference 2022
DIA - Medical Information & Communications Conference 2022 October 5th – 6th - Barcelona This is a unique meeting organised by medical information professionals for medical information professionals. A coming together from across the world to openly [...]
Trusted Partners
We work with a trusted, select group of partners for their experience, their reliability and most importantly because they offer the same quality of service and commitment to client satisfaction as ESMS Global.
“ESMS, a spin-out from Guy’s Hospital Poisons Unit, provides a unique service to clinical trials that goes beyond a simple unblinding service of the type that an NHS on-call pharmacist might provide.
This service is designed to prevent inappropriate unblinding as in most cases, the A&E doctor is confident to proceed with the patient`s treatment without unblinding, thus improving patient retention and reducing the need for higher patient recruitment.
Retaining patients on study is also crucial to the success of the grant.”
